biote Corp. (BTMD) stock

BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30

$1.06+0.03 (+3.40%)

Close on Nov 13, 2026Market cap $38.26MP/E –Yield –

biote EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

biote's EV/EBITDA was 8.4× on Nov 11, 2026, against 5.1× a year earlier. Over the last 3 years it ranged from 2.1× to 9.4×, with a median of 5.4×.

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	8.4×	+3.4
2025	Dec 31, 2025	5.0×	−2.4
2024	Dec 31, 2024	7.3×	+3.8
2023	Dec 29, 2023	3.5×	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BTMD.

Revenue growth-8.6% · median -6.6%

Gross margin67.5% · median 44.0%

Operating margin5.0% · median 1.5%

Net margin-1.1% · median 0.6%

Advertisement
300 × 250

See a number that looks wrong?